350: Amniocentesis does not increase the risk of miscarriage in patients with positive prenatal screening - 19/12/14
Doi : 10.1016/j.ajog.2014.10.396
Linda Cowan 1, Mary Norton 2, Sara Goldman 3, Monica Flessel 3, Laura Jelliffe-Pawlowski 4, Dena Towner 5, Robert Currier 3
1 David Geffin School of Medicine at UCLA, Dept of Obstetrics and Gynecology, Los Angeles, CA
2 University of California San Francisco, Dept of Obstetrics, Gynecology, and Reproductive Sciences, San Francisco, CA
3 California Department of Public Health, Genetic Disease Screening Program, Sacramento, CA
4 University of California San Francisco, Dept of Epidemiology and Biostatistics, San Francisco, CA
5 John A Burns School of Medicine, Dept of Obstetrics, Gynecology, and Women's Health, Manoa, HI
Le texte complet de cet article est disponible en PDF.
Plan
© 2015
Publié par Elsevier Masson SAS.
Vol 212 - N° 1S
P. S184 - janvier 2015 Retour au numéro
Article précédent
- 349: Maternal and neonatal outcomes after antenatal corticosteroid administration for PPROM at 32-33 6/7 weeks gestational age
- Lili Sheibani, Alex Fong, Dana Henry, Mary Norton, Yen Truong, Adanna Anyikam, Louise Laurent, Rashmi Rao, Deborah Wing
- 351: Meconium stained amniotic fluid in low risk pregnancies at term – Is it really a clinical entity?
- Liran Hiersch, Eran Ashwal, Amir Aviram, Rinat Gabbay-Benziv, Arnon Wiznitzer, Yariv Yogev
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?